Effect of ultrasound-guided stellate ganglion block on intrapulmonary shunt and oxygenation in one-lung ventilation

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200063210

Enrollment

Unknown

Registered

2022-09-01

Start date

2022-09-01

Completion date

Unknown

Last updated

2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung lobe surgery

Interventions

Control group:NA

Experimental group:stellate ganglion block with ropivacaine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective thoracoscopic lobectomy; 2. Aged 18-75 years; 3. ASA grade I-III.

Exclusion criteria

Exclusion criteria: 1. FEV1/FVC < 70%; 2. History of asthma and COPD, acute lung infection; 3. History of pulmonary surgery; 4. Failure of stellate ganglion block; 5. History of preoperative chemoradiotherapy; 6. Intraoperative SpO2 less than 90% lasting 15 minutes; 7. Intraoperative blood transfusion; 8. Intraoperative one-lung ventilation less than 1 hour; 9. Serious complications such as massive bleeding and anaphylactic shock occurred during operation; 10. Who switched to open-heart surgery.

Design outcomes

Primary

Measure	Time frame
Tumor Necrosis Factor-a;interleukin-8;interleukin-1;interleukin-6;Oxygenation index;Intrapulmonary shunt;	—

Countries

China

Contacts

Public ContactGuoshao Zhu

Quanzhou First Hospital Affiliated to Fujian Medical University

fjzgs@fjmu.edu.cn+86 15980738606

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026